SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
HONG KONG, Jan. 19, 2026 /PRNewswire/ -- Harvest Global Investments Limited ("HGI"), the international subsidiary of Harvest Fund Management, today announced a new round of...
HONG KONG, Jan. 19, 2026 /PRNewswire/ -- SHIMENG SUPPLY CHAIN MANAGEMENT CO., LTD. ("SHIMENG"), an investee company of Shoucheng Holdings (0697.HK), has recently initiated...
HONG KONG, Jan. 19, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced that its supplemental New Drug Application (sNDA) for gumokimab (AK111), a novel humanized anti-IL-17A monoclonal...